Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Isfordink, CJ; Boyd, A; Sacks-Davis, R; van Santen, DK; Smit, C; Martinello, M; Stoove, M; Berenguer, J; Wittkop, L; Klein, MB; Rauch, A; Salmon, D; Lacombe, K; Stewart, A; Schinkel, J; Doyle, JS; Hellard, M; van der Valk, M; Matthews, GV.

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study

LANCET PUBLIC HEALTH. 2023; 8(4): 294-304

Veintimilla, C; Alvarez-Uria, A; Martin-Rabadan, P; Valerio, M; Machado, M; Padilla, B; Alonso, R; Diez, C; Munoz, P; Marin, M.

Pneumocystis jirovecii Pneumonia Diagnostic Approach: Real-Life Experience in a Tertiary Centre

Journal of Fungi. 2023; 9(4): Nº de citas: 9 [doi:10.3390/jof9040414]

Cobos, A; Valerio, M; Palomo, M; Adan, I; Catalan, P; Veintimilla, C; Lopez-Andujar, F; Rincon, C; Galar, A; Alonso, R; Machado, M; Gijon, P; Lois, TAE; Latorre, LP; Diez, C; Fanciulli, C; Santiago, EB; Munoz, P.

Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(2): 194-200 Nº de citas: 6 [doi:10.37201/req/112.2022]

Bouza, E; Arango, C; Moreno, C; Gracia, D; Martin, M; Perez, V; Lazaro, L; Ferre, F; Salazar, G; Tejerina-Picado, F; Navio, M; Revilla, JG; Palomo, E; Gil-Monte, PR.

Impact of the COVID-19 pandemic on the mental health of the general population and health care workers

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2023; 36(2): 125-143 Nº de citas: 8 [doi:10.37201/req/018.2023]

Perez-Molina, JA; Crespillo-Andujar, C; Zamora, J; Fernandez-Felix, BM; Gaetano-Gil, A; de Quiros, JCLB; Serrano-Villar, S; Moreno, S; Alvarez-Diaz, N; Berenguer, J.

Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis

CLINICAL INFECTIOUS DISEASES. 2023; 76(11): 2027-2037 Nº de citas: 8 [doi:10.1093/cid/ciad177]

TARANCON, L..

Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy

BIOMEDICINE & PHARMACOTHERAPY. 2023; 162: Nº de citas: 1 [doi:10.1016/j.biopha.2023.114587]

Berenguer J; Jarrín I; Bellón JM; Díez C; Jiménez-Sousa MA; Roca C; González-García J; Dalmau D; Olalla J; Herrero C; Villarroya F; Domingo P; Resino S.

Obesity-related SNPs and weight gain following first-line antiretroviral therapy.

CLINICAL INFECTIOUS DISEASES. 2023; 76(6): 977-985 Nº de citas: 6 [doi:10.1093/cid/ciac880]

Ramírez M; Palmar-Santos A; Pedraz-Marcos A; Brañas F.

An exploratory prospective study of the factors associated with adverse health outcomes in older adults living with HIV.

Medwave. 2023; 23(2): [doi:10.5867/medwave.2023.02.2613]

Ramirez, M; Palmar-Santos, A; Sanchez-Conde, M; Pedraz-Marcos, A; Branas, F.

A prospective exploratory study of the factors associated with adverse health outcomes in older adults living with HIV

Medwave. 2023; 23(2):

Salgnero, S; Brochado-Kith, O; Verdices, AV; Berenguer, J; Gonzalez-Garcia, J; Martinez, I; Diez, C; Hontanon, V; Perez-Latorre, L; Fernandez-Rodriguez, A; Jimenez-Sousa, MA; Resino, S.

PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study

BIOMEDICINE & PHARMACOTHERAPY. 2023; 159: Nº de citas: 2 [doi:10.1016/j.biopha.2023.114220]

van Santen DK; Sacks-Davis R; Stewart A; Boyd A; Young J; van der Valk M; Smit C; Rauch A; Braun DL; Jarrin I; Berenguer J; Lazarus JV; Lacombe K; Requena MB; Wittkop L; Leleux O; Salmon D; Bonnet F; Matthews G; Doyle JS; Spelman T; Klein MB; Prins M; Asselin J; Stoové MA; Hellard M.

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: findings from a multinational cohort between 2010 and 2019

Eclinicalmedicine. 2023; 56: 101810-101810 Nº de citas: 22 [doi:10.1016/j.eclinm.2022.101810]

Sepulveda-Crespo, D; Trevino-Nakoura, A; Bellon, JM; Jimenez-Sousa, MA; Ryan, P; Martinez, I; Fernandez-Rodriguez, A; Resino, S.

Diagnostic Performance of the HCV Core Antigen Test To Identify Hepatitis C in HIV-Infected Patients: a Systematic Review and Meta-Analysis

JOURNAL OF CLINICAL MICROBIOLOGY. 2023; 61(1): Nº de citas: 4 [doi:10.1128/jcm.01331-22]

Branas, F; Torralba, M; Antela, A; Vergas, J; Ramirez, M; Ryan, P; Dronda, F; Galindo, MJ; Machuca, I; Bustinduy, MJ; Cabello, A; Montes, ML; Sanchez-Conde, M.

Effects of frailty, geriatric syndromes, and comorbidity on mortality and quality of life in older adults with HIV

BMC GERIATRICS. 2023; 23(1): Nº de citas: 23 [doi:10.1186/s12877-022-03719-8]

Polo R; García-Albéniz X; Terán C; Morales M; Rial-Crestelo D; Garcinuño MA; García Del Toro M; Hita C; Gómez-Sirvent JL; Buzón L; Díaz de Santiago A; Arellano JP; Sanz J; Bachiller P; Alfaro EM; Díaz-Brito V; Masiá M; Hernández-Torres A; Guerra JM; Santos J; Arazo P; Muñoz L; Arribas JR; Martínez de Salazar P; Moreno S; Hernán MA; Del Amo J.

Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers

CLINICAL MICROBIOLOGY AND INFECTION. 2023; 29(1): 85-93 Nº de citas: 10 [doi:10.1016/j.cmi.2022.07.006]

Maggiolo, F; Rizzardini, G; Molina, JM; Pulido, F; De Wit, S; Vandekerckhove, L; Berenguer, J; D'Antoni, ML; Blair, C; Chuck, SK; Piontkowsky, D; Martin, H; Haubrich, R; McNicholl, IR; Gallant, J.

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people >= 65 years of age

HIV MEDICINE. 2023; 24(1): 27-36 Nº de citas: 26 [doi:10.1111/hiv.13319]

Fernandez-Pato, A; Virseda-Berdices, A; Resino, S; Ryan, P; Martinez-Gonzalez, O; Perez-Garcia, F; Martin-Vicente, M; Valle-Millares, D; Brochado-Kith, O; Blancas, R; Martinez, A; Ceballos, FC; Bartolome-Sanchez, S; Vidal-Alcantara, EJ; Alonso, D; Blanca-Lopez, N; Martinez-Acitores, IR; Martin-Pedraza, L; Jimenez-Sousa, MA; Fernandez-Rodriguez, A.

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

Emerging Microbes & Infections. 2022; 11(1): 676-688 Nº de citas: 65 [doi:10.1080/22221751.2022.2038021]

Alonso-Menchén D; Muñoz P; Sánchez-Carrillo C; Pérez-Latorre L; Bouza E.

Unresolved issues in the epidemiology and diagnosis of bacteremia: an opinion paper

REVISTA ESPANOLA DE QUIMIOTERAPIA. 2022; 35(6): 519-537 Nº de citas: 7 [doi:10.37201/req/066.2022]

Lodi, S; Klein, M; Rauch, A; Epstein, R; Wittkop, L; Logan, R; Rentsch, CT; Justice, AC; Touloumi, G; Berenguer, J; Jarrin, I; Egger, M; Puoti, M; Monforte, AD; Gill, J; Ceron, DS; van Sighem, A; Linas, B; van der Valk, M; Hernan, MA.

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection

Journal of the International AIDS Society. 2022; 25(12): Nº de citas: 9 [doi:10.1002/jia2.26048]